NRXP
NRX PHARMACEUTICALS INC
πΊπΈ NYSE/NASDAQ
π Overview
π Performance
π΅ Cost
π Esg
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
-19.74%
Annual Growth
5 years average annual growth
π
2
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic. The Company is also engaged in the development of its new product, NRX-102.
π Performance
Price History*
-98.56%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$1.39
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in NRXP
2
π Total Capital Earnings
N/A
π Average investment frequency
7 weeks
π΅ Average investment amount
$259
β° Last time a customer invested in NRXP
258 days
NRXP investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50%
50k - 100k
Less than 50k
50%
πΆ Age of investors
18 - 25
26 - 34
50%
35 - 90
50%
π Legal gender of investors
Female
Male
100%
Pearlers who invest in NRXP also invest in...
π Performance (5Yr p.a)
1043.13%
π Share price
$171.29 USD
π Performance (5Yr p.a)
-1.79%
π Share price
$58.70 USD
π Performance (5Yr p.a)
494.41%
π Share price
$135.40 USD
π HIGH PRICE GROWTH
Want more shares? Try these...